Clinical Trials in New York

Showing 17301-17320 of 22,668 trials

Open-label Ziprasidone Study for Psychosis Treatment in Adolescents

NCT00421954

This open-label study will assess the medication Geodon® (Ziprasidone) in pediatric patients, aged 13-17, diagnosed with psychotic disorder. Eligible adolescents will receive Geodon® for 7 weeks and stay at the NYSPI Children's Day Unit (CDU) during the day. If clinically appropriate, they may also stay at the New York State Psychiatric Institute (NYSPI) Schizophrenia Research Unit (SRU) inpatient facility.

Schizophreniform DisorderSchizoaffective DisorderPsychosis+2 more

New York State Psychiatric Institute8 participantsStarted May 2006

New York, New York, United States

COMPLETEDPhase 3< 1 mile

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

NCT01931150

The purpose of this study is to see if the investigators can prevent or reduce the severity of the Cetuximab-related acne rash. Two different topical agents will be applied to the skin. One topical agent is the dapsone gel and the other is a skin moisturizer. Dapsone gel is an FDA approved medication that you apply to the face. It is commonly used to treat acne. Skin moisturizers are recommended to patients who receive Cetuximab treatment. In addition to these topical agents they will be given a pill to take once a day. This pill has already been shown to help fight rashes from Cetuximab.

Cetuximab-induced Papulopustular (Acneiform) Rash Who HaveMetastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma

Memorial Sloan Kettering Cancer Center11 participantsStarted Aug 2013

New York, New York, United States

COMPLETEDPhase 1< 1 mile

Prepulse Inhibition of Startle in Cocaine Dependence - 7

NCT00015249

The purpose of this study is to assess the effects of chronic cocaine use on the acoustic startle response and on gating of this response in humans.

National Institute on Drug Abuse (NIDA)Started Feb 1997

New York, New York, United States

Open-label Ziprasidone Study for Psychosis Treatment in Adolescents

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Prepulse Inhibition of Startle in Cocaine Dependence - 7

Find Trials by Condition in New York

Modafinil for the Treatment of Cocaine Dependence - 1

Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases

Trial of NovoSeven® in Haemophilia - Joint Bleeds

Risperidone Treatment in Dually-Diagnosed Individuals - 2

Cocaine Abuse and Attention Deficit Disorder - 3

IV Cocaine Abuse: A Laboratory Model - 4

Buprenorphine and Naloxone Combination Study - 10

Cocaine Effects in Humans: Physiology and Behavior - 1

Effects of Buspirone in Opiate Withdrawal

Predictive Values of Serotonergic Alterations for Outcome - 2

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

Use of Activated Recombinant Human Factor VII in Cardiac Surgery

GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

Treatment of Congenital Factor VII Deficiency

HIV and HCV Intervention In Drug Treatment Settings - 1

Reserpine for the Treatment of Cocaine Dependence - 1

Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury